These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12549672)

  • 1. Current trends in lead discovery: are we looking for the appropriate properties?
    Oprea TI
    Mol Divers; 2002; 5(4):199-208. PubMed ID: 12549672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends in lead discovery: are we looking for the appropriate properties?
    Oprea TI
    J Comput Aided Mol Des; 2002; 16(5-6):325-34. PubMed ID: 12489682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead-like, drug-like or "Pub-like": how different are they?
    Oprea TI; Allu TK; Fara DC; Rad RF; Ostopovici L; Bologa CG
    J Comput Aided Mol Des; 2007; 21(1-3):113-9. PubMed ID: 17333482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Property distribution of drug-related chemical databases.
    Oprea TI
    J Comput Aided Mol Des; 2000 Mar; 14(3):251-64. PubMed ID: 10756480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a difference between leads and drugs? A historical perspective.
    Oprea TI; Davis AM; Teague SJ; Leeson PD
    J Chem Inf Comput Sci; 2001; 41(5):1308-15. PubMed ID: 11604031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J; Cooper MA
    Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of theoretical methods of calculation of partition coefficients for selected drugs.
    Pyka A; Babuśka M; Zachariasz M
    Acta Pol Pharm; 2006; 63(3):159-67. PubMed ID: 20085219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyond.
    Odi R; Bibi D; Wager T; Bialer M
    Epilepsia; 2020 Aug; 61(8):1543-1552. PubMed ID: 32614073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pursuing the leadlikeness concept in pharmaceutical research.
    Hann MM; Oprea TI
    Curr Opin Chem Biol; 2004 Jun; 8(3):255-63. PubMed ID: 15183323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-high-throughput screening analysis: an empirical compound prioritization scheme.
    Oprea TI; Bologa CG; Edwards BS; Prossnitz ER; Sklar LA
    J Biomol Screen; 2005 Aug; 10(5):419-26. PubMed ID: 16093551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of logP predictions based on calculated molecular descriptors: a critical review.
    Eros D; Kövesdi I; Orfi L; Takács-Novák K; Acsády G; Kéri G
    Curr Med Chem; 2002 Oct; 9(20):1819-29. PubMed ID: 12369880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical substructures in drug discovery.
    Merlot C; Domine D; Cleva C; Church DJ
    Drug Discov Today; 2003 Jul; 8(13):594-602. PubMed ID: 12850335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity.
    Hill AP; Young RJ
    Drug Discov Today; 2010 Aug; 15(15-16):648-55. PubMed ID: 20570751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of physiochemical property profiles of development and marketed oral drugs.
    Wenlock MC; Austin RP; Barton P; Davis AM; Leeson PD
    J Med Chem; 2003 Mar; 46(7):1250-6. PubMed ID: 12646035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using measured pKa, LogP and solubility to investigate supersaturation and predict BCS class.
    Box KJ; Comer JE
    Curr Drug Metab; 2008 Nov; 9(9):869-78. PubMed ID: 18991583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Computerized logP prediction using fragment methods].
    Takácsné NK
    Acta Pharm Hung; 1998 Jan; 68(1):39-48. PubMed ID: 9528148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships.
    Cheng A; Merz KM
    J Med Chem; 2003 Aug; 46(17):3572-80. PubMed ID: 12904062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.